Insurer margins tighten as government targets specialist fees

The reform agenda pulling health funds two ways

Insurer margins tighten as government targets specialist fees

Life & Health

By Roxanne Libatique

Australian health insurers are entering a period of tightening margins just as the federal government moves to force greater transparency on the specialist fees and billing practices that drive members’ out-of-pocket costs, setting up a reform agenda whose commercial stakes cut in more than one direction for the sector.

Margins narrow as out-of-pocket costs climb

Industry earnings have softened. According to Australian Prudential Regulation Authority (APRA) data, net profit after income tax from continuing operations fell to $210 million in the March 2026 quarter, down from $417 million in the December 2025 quarter and $431 million a year earlier. Health insurance business net margin narrowed to 3.6%, from 4.5% in the prior quarter and 5.5% in March 2025, while the investment result was a $14 million loss for the quarter. Insurance revenue of $8,523 million ran against insurance service expense of $8,088 million.

At the same time, member costs are rising. APRA reported the average out-of-pocket payment for a hospital episode reached $511.02 in the March 2026 quarter, up 8.9% year-on-year, with the orthopaedic specialty group recording the largest average medical gap at $849.93. The government has cited that 8.6% of people delayed or missed specialist care because of cost in 2024-25, and has said the most common cause of out-of-pocket costs is specialist fees. Grattan Institute analysis found specialist fees have risen 73% since 2010, that patients pay a fee for two-thirds of specialist appointments and are charged $300 a year on average, and that more than one in five people who saw a specialist in 2023 were charged an extreme fee – defined as more than three times the Medicare schedule fee – at least once.

Two regulatory fronts opening at once

The government is advancing on parallel tracks, using consultation to shape some measures while legislating others where it judges voluntary approaches to have failed. The Department of Health, Disability and Ageing has opened its second consultation in a specialist-affordability series, “Fee Transparency in Health Care,” examining informed financial consent (IFC) and split billing, with submissions closing on Aug. 5, 2026. The paper states IFC is not established as an enforceable patient right, with obligations fragmented across professional standards and general consumer law, and sets out reform options ranging from expanding the Professional Services Review to establishing a dedicated regulator.

Split billing is a direct concern for insurers. The paper describes it as separating a single episode of care across billing arrangements – often through administration or booking fees – in ways that can circumvent no-gap and known-gap arrangements. It cites Private Healthcare Australia (PHA) research finding 29% of patients were charged administration or booking fees and that consumers could be paying $20 million in hidden fees and deposits.

Running alongside the consultation, the government has introduced the Health Legislation Amendment (Improving Choice and Transparency for Private Health Consumers) Bill 2026, which would publish individual specialists’ fees on the Medical Costs Finder using Medicare, hospital, and insurer billing data. The Senate’s Community Affairs Legislation Committee, to which the Bill was referred, reported on April 15, 2026, and the Bill remains before the House of Representatives, its originating house. Health Minister Mark Butler said a voluntary disclosure model had failed, with only about 88 of roughly 6,300 eligible specialists displaying fees by 2025. “Specialists and private health funds have been given the opportunity to be upfront about patient costs and out of pocket expenses but frankly, have failed to do so,” Butler said.

The same bill targets insurers directly. It would outlaw “product phoenixing” – closing a product and reopening a near-identical one at a higher price – and require insurers to seek ministerial approval for premiums on new products and for certain changes that reduce the cover or value of existing ones. The Department’s Impact Analysis estimated the change would add regulatory costs averaging about $17,000 per year per insurer across 28 insurers and identified reduced flexibility to respond to below-expected product margins as the most notable impact for insurers.

The rebate cut raises the participation stakes

The reform agenda coincides with a measure that industry bodies warn could weaken the risk pool. The government has announced its intention to reduce the higher private health insurance rebate for people aged 65 and over to the level applying to under-65s, from April 1, 2027, to fund aged care. The Department’s Impact Analysis frames the current age-based rebate as creating intergenerational inequity.

Members Health said the change could affect up to 3 million older Australians, citing independent actuarial modelling that removing the higher rebates would reduce Commonwealth expenditure by about $482 million while shifting roughly $547 million in additional costs onto public hospitals. Private Healthcare Australia noted about 39% of people with private cover earn under $55,000, including more than 900,000 older Australians affected by the change, and proposed redirecting support to low-income members rather than removing age tiers outright.

Commercial implications

The limbs of the agenda pull against each other for insurers, and on different horizons. The rebate cut, from April 2027, threatens participation among older, higher-claiming members, the cohort most costly to lose from the risk pool. The transparency and billing measures now before Parliament could, by contrast, work in insurers’ favour: lower gaps and curbed split billing would reduce the out-of-pocket costs that drive members to downgrade or drop cover, potentially strengthening the perceived value of a policy and supporting retention. Set against that, the premium-approval and anti-phoenixing rules constrain a pricing lever at a time when margins are already thin.

PHA chief executive Dr. Rachel David said each proposal should be tested against its effect on premiums. “Affordability must remain the guiding principle throughout this reform process,” she said, adding that “any proposal that increases premiums risks making health insurance less affordable for Australian families.”

A House of Representatives inquiry into specialist access and affordability is accepting submissions until Oct. 16, 2026, and further consultation papers are expected.

Related Stories

Keep up with the latest news and events

Join our mailing list, it’s free!